Magisca Pharmaceuticals Private Limited
About Magisca Pharmaceuticals Private Limited
Data last updated:
Magisca Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2017PTC310622.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ashish Gupta and Vinay Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 507/6A G/F Shambhav Cly Mandi Pahari Near Ramlila, Maidan, New Delhi, Delhi, India – 110047.
As per the financials filed for FY 2025, the company reported a revenue of ₹63,622, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹545 (net margin 0.9%) and EBITDA of ₹736 (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 2% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Magisca Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH. No. 507/6A G/F Shambhav Cly Mandi Pahari Near Ramlila, Maidan, New Delhi, Delhi, India – 110047
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Magisca Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Magisca Pharmaceuticals is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of Magisca Pharmaceuticals Private Limited, buy the company report.
Financials of Magisca Pharmaceuticals Private Limited
FY 2025 filings availableMagisca Pharmaceuticals Private Limited reported revenue of ₹63,622 (down 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 33% fall in the latest year. EBITDA fell 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹736 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹545 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Magisca Pharmaceuticals Private Limited, buy the company report.
Board of directors of Magisca Pharmaceuticals Private Limited
Magisca Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Gupta | Director | 16 Jan 2017 | 9 Years 9 Months | Current |
| Vinay Kumar Gupta | Director | 16 Jan 2017 | 9 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Magisca Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Magisca Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Magisca Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Magisca Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Ashish Gupta was appointed as Director on 16 Jan 2017.
Frequently asked questions
Magisca Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 January 2017 (9+ years old) and is registered under CIN U24290DL2017PTC310622.
Magisca Pharmaceuticals has 2 current directors:
- Ashish Gupta - Director
- Vinay Kumar Gupta - Director
The latest financial statements of Magisca Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Magisca Pharmaceuticals is U24290DL2017PTC310622. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Magisca Pharmaceuticals was incorporated on 16 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Ashish Gupta was appointed as Director on 16 Jan 2017. Vinay Kumar Gupta was appointed as Director on 16 Jan 2017.
The registered office of Magisca Pharmaceuticals is at H. No. 5076A GF Shambhav Cly Mandi Pahari Near Ramlila, Maidan, New Delhi, Delhi, India – 110047.
Magisca Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Magisca Pharmaceuticals is active non-compliant as of 10 August 2026. The company is actively filing with the Registrar of Companies.
Magisca Pharmaceuticals can be reached at its registered office: H. No. 5076A GF Shambhav Cly Mandi Pahari Near Ramlila, Maidan, New Delhi, Delhi, India – 110047.